We are monitoring the impact of COVID-19 on Asia Pacific Virology Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 4932
Share on
Share on

Asia Pacific Virology Market Research Report – Segmented By Type, Application, End User and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Forecast (2020 to 2025)

Pulished: February, 2020
ID: 4932
Pages: 145

The size of the Asia Pacific Virology Market is expected to grow at a prominent CAGR from 2020 to 2025.

Virology refers to the study of viruses which are sub microscopic, parasitic particles of genetic material contained in a protein coat and virus-like agents. It mainly focuses on their structure, classification and evolution, their ways to infect and exploit host cells for reproduction, their interaction with host organism physiology and immunity, the they cause, the techniques to isolate and culture them, and their use in research and therapy. Virology is generally considered as subfield of microbiology.

The significant drivers are various treatments and diagnostic processes that use virology application. Increasing applications of virology in gene therapy, phage therapy, formulation of vaccines etc. is also expected to boost the market. Increasing Public awareness programmes conducted worldwide on flu, zika virus, STDs, AIDS, and Ebola virus is also a key factor driving the market. However, quality and safety standards are a longstanding challenge, and stringent approval processes for antiviral drugs may limit the growth of this industry.

The Asia Pacific Virology market is segmented on the basis of Type, application, end user and region. Based on Type the market is segmented into Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons. Based on Application the market is segmented into Skin and Soft Tissue Infections, GI Tract Infections, Urinary Tract infection, Eye Infections, Respiratory Tract Infections, Sexually Transmitted, Perinatal Infections. STDs, Urinary tract infections, and respiratory tract infections. Based on end user the market is segmented into hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, and Pharmacies. Hospitals and Clinics are largest segment which account for nearly 50% of the market share.

Asia Pacific is geographically segmented into China, India, Japan, South Korea, Taiwan, Australia and South East Asia. Asia Pacific region is expected to witness significant growth. China is expected to dominate the market followed by India.

Boehringer Ingelheim Corporation, Merck and Co. Inc, GlaxoSmithKline plc, Abbott Laboratories, Novartis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche. are the some of the key players in the Asia Pacific Virology market.

  1. INTRODUCTION
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. RESEARCH METHODOLOGY
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. OVERVIEW
    1. Executive Summary
    2. Key Inferences
  4. DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ANALYSIS
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. MARKET SEGMENTATION
    1. Type
      1. Introduction
      2. Diagnosing Test
        1. DNA Viruses
        2. RNA Viruses
        3. Prions Diagnostic Test
        4. Other Viral Tests
      3. Viral Infection Controlling Methods
        1. Immunoprophylaxis
        2. Active Prophylaxis (Vaccines)
        3. Passive Prophylaxis
      4. Antiviral Chemotherapy
        1. Virucidal Agents
        2. Antiviral Agents
        3. Immunomodulators
      5.                    Interferons
        1. Cytokines
      6. Y-o-Y Growth Analysis, By Type
      7. Market Attractiveness Analysis, By Type                 
      8. Market Share Analysis, By Type
    2. Application           
      1. Introduction
      2. Skin and Soft Tissue Infections
      3. Respiratory Tract Infections
      4. GI Tract Infections
      5. Urinary Tract Infections
      6. Eye Infections
      7. CNS Infections
      8. Sexually Transmitted Diseases
      9. Perinatal Infections
      10. Y-o-Y Growth Analysis, By Application
      11. Market Attractiveness Analysis, By Application
      12. Market Share Analysis, By Application
    3. End User
      1. Introduction
      2. Hospitals
      3. Clinics
      4. Laboratories
      5. Diagnostic Centres
      6. Blood Banks
      7. Pharmacies
      8. Y-o-Y Growth Analysis, By End User
      9. Market Attractiveness Analysis, By End User
      10. Market Share Analysis, By End User
  6. GEOGRAPHICAL ANALYSIS
    1. Introduction
      1. Regional Trends
      2. Impact Analysis
      3. Y-o-Y Growth Analysis
      4. Market Attractiveness Analysis
      5. Market Share Analysis
    2. Asia Pacific
      1. India
      2. China
      3. Japan
      4. South Korea
      5. Australia
      6. New Zealand
      7. Thailand
      8. Malaysia
      9. Vietnam
      10. Philippines
      11. Indonesia
      12. Singapore
      13. Rest of APAC
    3. STRATEGIC ANALYSIS
      1. PESTLE analysis
        1. Political
        2. Economic
        3. Social
        4. Technological
        5. Legal
        6. Environmental
    4. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  7. MARKET LEADERS' ANALYSIS
    1. Johnson & Johnson
      1. Overview
      2. Products
      3. Financials (subjected to availability based on company type)
      4. Recent Developments
      5. SWOT analysis
      6. Analyst View
    2. Abbott Laboratories
    3. GlaxoSmithKline plc
    4. Boehringer Ingelheim Corporation
    5. Merck and Co. Inc.
    6. Novartis International AG
    7. Siemens
    8. AstraZeneca AB
    9. Roche
  8. COMPETITIVE LANDSCAPE
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, collaborations and Joint Ventures
    4. New Product Launches
  9. MARKET OUTLOOK AND INVESTMENT OPPORTUNITIES
  10. APPENDIX
    1. List of Tables
    2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Type, application, end user and region along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Asia Pacific Virology Market, By Type, From 2020 TO 2025 (USD MILLION)
  2. Asia Pacific Diagnosing Test Market, By Region, From 2020 TO 2025 (USD MILLION)
  3. Asia Pacific Viral Infection Controlling Methods Market, By Region, From 2020 TO 2025 (USD MILLION)
  4. Asia Pacific Antiviral Chemotherapy Market, By Region, From 2020 TO 2025 (USD MILLION)
  5. Asia Pacific Interferons Market, By Region, From 2020 TO 2025 (USD MILLION)
  6. Asia Pacific Virology Market, By Application, From 2020 TO 2025 (USD MILLION)
  7. Asia Pacific Respiratory Tract Infections Market, By Region, From 2020 TO 2025 (USD MILLION)
  8. Asia Pacific GI Tract Infections Market, By Region, From 2020 TO 2025 (USD MILLION)
  9. Asia Pacific Urinary Tract Infections Market, By Region, From 2020 TO 2025 (USD MILLION)
  10. Asia Pacific Eye Infections Market, By Region, From 2020 TO 2025 (USD MILLION)
  11. Asia Pacific CNS Infections Market, By Region, From 2020 TO 2025 (USD MILLION)
  12. Asia Pacific Sexually Transmitted Diseases Market, By Region, From 2020 TO 2025 (USD MILLION)
  13. Asia Pacific Perinatal Infections Market, By Region, From 2020 TO 2025 (USD MILLION)
  14. Asia Pacific Virology Market, By End User, From 2020 TO 2025 (USD MILLION)
  15. Asia Pacific Hospitals Market, By Region, From 2020 TO 2025 (USD MILLION)
  16. Asia Pacific Clinics Market, By Region, From 2020 TO 2025 (USD MILLION)
  17. Asia Pacific Laboratories Market, By Region, From 2020 TO 2025 (USD MILLION)
  18. Asia Pacific Diagnostic Centres Market, By Region, From 2020 TO 2025 (USD MILLION)
  19. Asia Pacific Blood Banks Market, By Region, From 2020 TO 2025 (USD MILLION)
  20. Asia Pacific Pharmacies Market, By Region, From 2020 TO 2025 (USD MILLION)
  21. Japan Virology Market, By Type, From 2020 TO 2025 (USD MILLION)
  22. Japan Virology Market, By Application, From 2020 TO 2025 (USD MILLION)
  23. Japan Virology Market, By End User, From 2020 TO 2025 (USD MILLION)
  24. China Virology Market, By Type, From 2020 TO 2025 (USD MILLION)
  25. China Virology Market, By Application, From 2020 TO 2025 (USD MILLION)
  26. China Virology Market, By End User, From 2020 TO 2025 (USD MILLION)
  27. India Virology Market, By Type, From 2020 TO 2025 (USD MILLION)
  28. India Virology Market, By Application, From 2020 TO 2025 (USD MILLION)
  29. India Virology Market, By End User, From 2020 TO 2025 (USD MILLION)
  30. Australia Virology Market, By Type, From 2020 TO 2025 (USD MILLION)
  31. Australia Virology Market, By Application, From 2020 TO 2025 (USD MILLION)
  32. Australia Virology Market, By End User, From 2020 TO 2025 (USD MILLION)
  33. South Korea Virology Market, By Type, From 2020 TO 2025 (USD MILLION)
  34. South Korea Virology Market, By Application, From 2020 TO 2025 (USD MILLION)
  35. South Korea Virology Market, By End User, From 2020 TO 2025 (USD MILLION)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample